Mid-Term Vascular Safety of Renal Denervation Assessed by Follow-up MR Imaging

CardioVascular and Interventional Radiology

Volumn 39, Issue 3, 2016, Pages 426-432

  Schmid, Axel ^a   Schmieder, Raphael ^a   Lell, Michael ^a   Janka, Rolf ^a   Veelken, Roland ^a   Schmieder, Roland E ^a   Uder, Michael ^a   Ott, Christian ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Follow up; Magnetic resonance angiography; Renal artery stenosis; Renal denervation; Renal function; Safety

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIURETIC AGENT; GADOBUTROL;

ADULT; ARTICLE; CATHETER; CLINICAL TRIAL; CONVENTIONAL ANGIOGRAPHY; DIGITAL SUBTRACTION ANGIOGRAPHY; FEMALE; FOLLOW UP; HUMAN; KIDNEY ARTERY; KIDNEY DENERVATION; KIDNEY FUNCTION; KIDNEY PARENCHYMA; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PATIENT SAFETY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RESISTANT HYPERTENSION; THREE DIMENSIONAL IMAGING; AGED; CATHETER ABLATION; DIAGNOSTIC IMAGING; HYPERTENSION; INNERVATION; KIDNEY; MIDDLE AGED; PROCEDURES; PROSPECTIVE STUDY; SYMPATHECTOMY; VASCULARIZATION;

AGED; CATHETER ABLATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; KIDNEY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL ARTERY; SYMPATHECTOMY;

EID: 84957431259     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-015-1192-2     Document Type: Article

References (31)

1. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet. 2009;373(9671):1275–81.
2. Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M. Renal sympathetic denervation in patients with treatment-resistant hypertension (the Symplicity HTN-2 trial): a randomised controlled trial. Lancet. 2010;376(9756):1903–9.
3. Ott C, Mahfoud F, Schmid A, Ditting T, Sobotka PA, Veelken R, Spies A, Ukena C, Laufs U, Uder M, et al. Renal denervation in moderate treatment-resistant hypertension. J Am Coll Cardiol. 2013;62(20):1880–6.
4. Schmid A, Ditting T, Sobotka PA, Veelken R, Schmieder RE, Uder M, Ott C. Does renal artery supply indicate treatment success of renal denervation? Cardiovasc Intervent Radiol. 2013;36(4):987–91.
5. Krum H, Schlaich MP, Sobotka PA, Böhm M, Mahfoud F, Rocha-Singh K, Katholi R, Esler MD. Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study. Lancet. 2014;383(9917):622–9.
6. Esler MD, Krum H, Schlaich M, Schmieder RE, Böhm M, Sobotka PA. Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial. Circulation. 2012;126(25):2976–82.
7. Bhatt DL, Kandzari DE, O’Neill WW, D’Agostino R, Flack JM, Katzen BT, Leon MB, Liu M, Mauri L, Negoita M, et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med. 2014;370(15):1393–401.
8. Bakris GL, Townsend RR, Flack JM, Brar S, Cohen SA, D’Agostino R, Kandzari DE, Katzen BT, Leon MB, Mauri L, et al. 12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial. J Am Coll Cardiol. 2015;65(13):1314–21.
9. Vonend O, Antoch G, Rump LC, Blondin D. Secondary rise in blood pressure after renal denervation. Lancet. 2012;380(9843):778.
10. Kaltenbach B, Id D, Franke JC, Sievert H, Hennersdorf M, Maier J, Bertog SC. Renal artery stenosis after renal sympathetic denervation. J Am Coll Cardiol. 2012;60(25):2694–5.
11. Pucci G, Battista F, Lazzari L, Dominici M, Boschetti E, Schillaci G. Progression of renal artery stenosis after renal denervation. Impact on 24-hour blood pressure. Circ J. 2014;78(3):767–8.
12. Bacaksiz A, Uyarel H, Jafarov P, Kucukbuzcu S. Iatrogenic renal artery stenosis after renal sympathetic denervation. Intern J Cardiol. 2014;172(3):e389–90.
13. Bhamra-Ariza P, Rao S, Muller DW. Renal artery stenosis following renal percutaneous denervation. Catheter Cardiovasc Interv. 2014;84(7):1180–3.
14. Versaci F, Trivisonno A, Olivieri C, Magri G, Caranci F, Prati F. Is an abnormal vascular response after renal sympathetic denervation predictive of permanent damage? An unusual case of late renal artery stenosis after energy delivery. J Endovasc Ther. 2014;21(2):191–6.
15. Templin C, Jaguszewski M, Ghadri JR, Sudano I, Gaehwiler R, Hellermann JP, Schoenenberger-Berzins R, Landmesser U, Erne P, Noll G, et al. Vascular lesions induced by renal nerve ablation as assessed by optical coherence tomography: pre- and post-procedural comparison with the Simplicity catheter system and the EnligHTN multi-electrode renal denervation catheter. Eur Heart J. 2013;34(28):2141–8.
16. Ierna S, Biondi-Zoccai G, Bachis C, Occhipinti M, Di Vito L, Ricciardi A, Pappone C, Prati F. Transcatheter renal sympathetic ablation for resistant hypertension: in vivo insights in humans from optical coherence tomography. Int J Cardiol. 2013;165(2):e35–7.
17. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560–72.
18. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, et al. ESH/ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31(7):1281–357.
19. O’Brien E, Pickering T, Asmar R, Myers M, Parati G, Staessen J, Mengden T, Imai Y, Waeber B, Palatini P, et al. Working Group on Blood Pressure Monitoring of the European Society of Hypertension International Protocol for validation of blood pressure measuring devices in adults. Blood Press Monit. 2002;7(1):3–17.
20. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.
21. Luetkens JA, Wilhelm K, Dusing R, Woitas RP, Thomas D, Hundt F, Doerner J, Schild HH, Nahle CP. Renal denervation: results of a single-center cohort study. Rofo. 2015;187(1):36–41.
22. Lambert T, Nahler A, Reiter C, Schwarz S, Gammer V, Blessberger H, Kammler J, Saleh K, Grund M, Steinwender C. Frequency of renal artery stenosis after renal denervation in patients with resistant arterial hypertension. Am J Cardiol. 2015;115(11):1545–8.
23. Papademetriou V, Tsioufis CP, Sinhal A, Chew DP, Meredith IT, Malaiapan Y, Worthley MI, Worthley SG. Catheter-based renal denervation for resistant hypertension: 12-month results of the EnligHTN I first-in-human study using a multielectrode ablation system. Hypertension. 2014;64(3):565–72.
24. Zhang ZH, Yang K, Jiang FL, Zeng LX, Jiang WH, Wang XY. The effects of catheter-based radiofrequency renal denervation on renal function and renal artery structure in patients with resistant hypertension. J Clin Hypertens. 2014;16(8):599–605.
25. Steigerwald K, Titova A, Malle C, Kennerknecht E, Jilek C, Hausleiter J, Nahrig JM, Laugwitz KL, Joner M. Morphological assessment of renal arteries after radiofrequency catheter-based sympathetic denervation in a porcine model. J Hypertens. 2012;30(11):2230–9.
26. Rippy MK, Zarins D, Barman NC, Wu A, Duncan KL, Zarins CK. Catheter-based renal sympathetic denervation: chronic preclinical evidence for renal artery safety. Clin Res Cardiol. 2011;100(12):1095–101.
27. Sakakura K, Tunev S, Yahagi K, O’Brien AJ, Ladich E, Kolodgie FD, Melder RJ, Joner M, Virmani R. Comparison of histopathologic analysis following renal sympathetic denervation over multiple time points. Circ Cardiovasc Interv. 2015;8(2):e001813.
28. Taylor GW, Kay GN, Zheng X, Bishop S, Ideker RE. Pathological effects of extensive radiofrequency energy applications in the pulmonary veins in dogs. Circulation. 2000;101(14):1736–42.
29. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, Kim YH, Klein G, Packer D, Skanes A. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation. 2005;111(9):1100–5.
30. Bakris GL, Williams M, Dworkin L, Elliott WJ, Epstein M, Toto R, Tuttle K, Douglas J, Hsueh W, Sowers J. Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis. 2000;36(3):646–61.
31. Mahfoud F, Cremers B, Janker J, Link B, Vonend O, Ukena C, Linz D, Schmieder R, Rump LC, Kindermann I, et al. Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension. Hypertension. 2012;60(2):419–24.